Chemical Component Summary

Synonyms(3R)-4-amino-3-(4-chlorophenyl)butanoic acid
Identifiers(3R)-4-azanyl-3-(4-chlorophenyl)butanoic acid
FormulaC10 H12 Cl N O2
Molecular Weight213.66
Isomeric SMILESc1cc(ccc1[C@@H](CC(=O)O)CN)Cl

Chemical Details

Formal Charge0
Atom Count26
Chiral Atom Count1
Bond Count26
Aromatic Bond Count6

Drug Info: DrugBank

DrugBank IDDB08891 
DescriptionArbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as a treatment for spasticity due to multiple sclerosis and spinal cord injury. Arbaclofen was investigated as a treatment for gastroesophageal reflux disease (GERD); however, with disappointing results.
  • (R)-Baclofen
  • Arbaclofen
  • (R)-4-amino-3-(4-chlorophenyl)butan¬≠oic acid
IndicationInvestigated in clinical trials as a potential treatment for spasticity in multiple sclerosis, autism spectrum disorder, and social withdrawal in fragile X syndrome.
CAS number69308-37-8

Drug Targets

NameTarget SequencePharmacological ActionActions
Gamma-aminobutyric acid type B receptor subunit 1MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQ...unknownagonist
Gamma-aminobutyric acid type B receptor subunit 2MASPRSSGQPGPPPPPPPPPARLLLLLLLPLLLPLAPGAWGWARGAPRPP...unknownagonist
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference